INS and sarcopenia: A cohort study involving patients with biopsy-confirmed MAFLD and skeletal muscle mass evaluations to characterize sarcopenia found a higher prevalence of sarcopenia in individuals with liver pathologies; sarcopenia was also related to the induction of a high degree of hepatic fibrosis, and this result is maintained regardless of the inflammatory state of the patient, insulin sensitivity, and obesity [174,175].